Quality appraisal of antibiotic prophylaxis guidelines to prevent infective endocarditis following dental procedures: a systematic review

Heba Hussein; Camila Montesinos-Guevara; Manal Abouelkheir; Ronald S Brown; Layal Hneiny; Yasser S Amer

doi:10.1016/j.oooo.2022.07.012

Quality appraisal of antibiotic prophylaxis guidelines to prevent infective endocarditis following dental procedures: a systematic review

Oral Surg Oral Med Oral Pathol Oral Radiol. 2022 Nov;134(5):562-572. doi: 10.1016/j.oooo.2022.07.012. Epub 2022 Jul 25.

Authors

Heba Hussein¹, Camila Montesinos-Guevara², Manal Abouelkheir³, Ronald S Brown⁴, Layal Hneiny⁵, Yasser S Amer⁶

Affiliations

¹ Department of Oral Medicine, Oral Diagnosis, and Periodontology, Faculty of Dentistry, Cairo University, Cairo, Egypt; Guidelines International Network, Perth, Scotland. Electronic address: [email protected].
² Centro de Investigación en Salud Pública y Epidemiología Clínica (CISPEC), Facultad de Ciencias de la Salud "Eugenio Espejo", Universidad UTE, Quito, Ecuador.
³ Department of Clinical Pharmacy, College of Pharmacy, Misr International University, Cairo, Egypt.
⁴ Department of Oral Diagnosis & Radiology, College of Dentistry Howard University, Washington, DC, USA; Georgetown University Medical Center, Washington, DC, USA.
⁵ Wegner Health Sciences Library, University Libraries, University of South Dakota, Vermillion, SD, USA.
⁶ Pediatrics Department and Clinical Practice Guidelines and Quality Research Unit, Quality Management Department, King Saud University Medical City, Riyadh, Saudi Arabia; Research Chair for Evidence-Based Health Care and Knowledge Translation, King Saud University, Riyadh, Saudi Arabia; Alexandria Center for Evidence-Based Clinical Practice Guidelines, Alexandria University Medical Council, Alexandria University, Alexandria, Egypt; Guidelines International Network, Perth, Scotland.

PMID: 36153302
DOI: 10.1016/j.oooo.2022.07.012

Abstract

Objective: To assess the quality of clinical practice guidelines (CPGs) for the use of antimicrobial prophylaxis to prevent infective endocarditis in indicated dental procedures.

Study design: We searched on Medline/OVID, CINAHL/EBSCO, and EMBASE from January 2011 to January 2022. We included de novo guidelines and excluded adapted or adopted guidelines, and guidelines published before 2011. The guidelines were independently appraised by 4 reviewers using the Appraisal of Guidelines for Research & Evaluation II (AGREE II) Instrument.

Results: Four eligible CPGs were appraised: the European Society of Cardiology, the American Heart Association, the National Institute of Health and Care Excellence (NICE), and the Japanese Circulation Society (JCS). Their AGREE II first overall assessments (OA1) were 63%, 58%, 92%, and 71%, respectively. Both NICE and JCS scored the highest in OA1 (>70%), Domain 3 Rigor of Development (85%, 65%), and Domain 5 Applicability (76%, 48%), respectively. The second overall assessment (OA2) of using the CPGs in daily practice was not significantly variable (recommended for use with modifications).

Conclusion: Three out of 4 CPGs support that the benefits of prevention of infective endocarditis outweigh the risks of antibiotic resistance.

Publication types

Systematic Review
Review

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antibiotic Prophylaxis
Endocarditis* / drug therapy
Endocarditis* / prevention & control
Endocarditis, Bacterial* / prevention & control
Humans

Substances

Anti-Bacterial Agents